TrialBeacon
USClinicalTrials.govClinical trialRecruiting

Sonablate HIFU International Registry for PC & BPH Patients

Open the official recordBack

Official record

Identifier
NCT07757490
Recruiting locations

country

United States
Interventions studied
High Intensity Focused Ultrasound
Lead sponsor
Sonablate
Target enrolment
10000 participants
Study type
OBSERVATIONAL
Phase
Not provided in the official record
Status
Recruiting
First posted
Aug 11, 2026
Last updated on the registry
Aug 13, 2026
Age
18 Years
Sex
MALE
Study contact
The official record lists a study contact. Contact details are published there and are intentionally not copied to this page.
Eligibility criteria

Reproduced verbatim from the official record. Eligibility is decided by the study team, never by this page.

Inclusion Criteria:

* Male with diagnosed localized prostate cancer or BPH (benign prostatic hyperplasia)
* Having undergone Sonablate HIFU ablation as part of standard clinical care, with all central data transmission subject to a mandatory 180-day post-procedure delay.

Exclusion Criteria:

* Prostate size or lesion location precluding effective HIFU target acquisition (prostate volume \>100 CC for prostate cancer or \>80 CC for BPH)
* Confirmed metastatic prostate cancer
* Prior radical prostatectomy
* Prostates with large calcifications (\>10mm causing shadowing)
* Prior rectal wall surgery or inability to undergo transrectal ultrasound
Indexed under
Prostate Cancer